Interview with Prof. Dr. Jeffrey Drebin, President of the 2024 President Elect of the American Surgical Association
2025
Interview with Prof. Dr. Jeffrey Drebin on Pancreatic Cancer Treatments
publication
Author Information
Author(s): Koshi Mimori, Tsutomu Fujii, Masayuki Sho, Itaru Endo, Ken Shirabe, Yuko Kitagawa
Primary Institution: Memorial Sloan Kettering Cancer Center
Conclusion
The interview discusses the potential of mRNA vaccines and neoadjuvant chemotherapy in treating pancreatic cancer, highlighting ongoing trials and the importance of personalized treatment approaches.
Supporting Evidence
- Dr. Drebin discusses the development of mRNA vaccines for pancreatic cancer before the COVID-19 pandemic.
- He emphasizes the importance of personalized neoantigens in vaccine therapy.
- The interview highlights ongoing trials for neoadjuvant chemotherapy combined with vaccines.
Takeaway
This article is an interview with a doctor who talks about new ways to treat pancreatic cancer, like using special vaccines and chemotherapy before surgery to help patients do better.
Methodology
The article is based on an interview format discussing various treatment strategies for pancreatic cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website